Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help

603 results

  1. xmlmplus_topics_2026-07-17.xml 
    https://medlineplus.gov/xml/mplus_topics_2026-07-17.xml
    ... institute><related-topic >Rashes</related-topic><see-reference >Atopic Dermatitis</see-reference><see-reference >Dermatitis</see-reference><site ><information-category > ...
  2. Clinical Review - Ruxolitinib (Opzelura) - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK619757
    ... bjd/ljad162.021 [ CrossRef ] 18. National Eczema Association. Atopic Dermatitis [sponsor-supplied reference] . 2023. Accessed January 12, 2024. https: ​//nationaleczema ​.org/ ...
  3. NLM Digital Collections - Dupilumab and crisaborole for atopic dermatitis : effectiveness and value : final evidence ... 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, June 8, 2017
    resource.nlm.nih.gov/101723893
    ... Flow Chart Showing Results of Literature Search for Atopic Dermatitis 616 potentially relevant references screened 510 citations excluded Population: 336 Intervention: 69 ...
  4. Pharmacoeconomic Review - Ruxolitinib (Opzelura) - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK619758
    ... Corporation. Clinical Study Report - Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 1 (TRuE-AD1) [sponsor-supplied reference] . 2021. 3. Incyte Corporation. Clinical Study Report -Topical ...
  5. Additional References of Potential Interest - Pimecrolimus for the Treatment of Adults with Atopic Dermatitis, ... 
    https://www.ncbi.nlm.nih.gov/books/NBK507659
    ... Potential Interest - Pimecrolimus for the Treatment of ... Additional References of Potential Interest - Pimecrolimus for the Treatment of Adults with Atopic Dermatitis, Seborrheic Dermatitis, or Psoriasis: A Review of Clinical ...
  6. Stakeholder Input - Dupilumab (Dupixent) - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK599844
    ... USask Dean’s Presentations, Sept 2022 Canadian Media References Poorly controlled, severe pediatric atopic dermatitis impacts with secondary skin infections seen in remote ...
  7. Eczema | Dermatitis | Atopic Dermatitis | MedlinePlus 
    https://medlineplus.gov/eczema.html
    ... gov: Eczema (National Institutes of Health) Journal Articles References and abstracts from MEDLINE/PubMed (National Library of Medicine) Article: Atopic dermatitis/eczema phenotypes and their association with food allergy: ...
  8. NLM Digital Collections - Index-catalogue of the Library of the Surgeon General's Office, National Library of Medicine .... 
    Publication: Washington : U.S. Dept. of Health, Education, and Welfare, Public Health Service : G.P.O., 1959-1961
    resource.nlm.nih.gov/8209737X1
    ... A. L. 1915) NORRLIND, Robert, 1907- "Prurigo Besnier (atopic dermatitis); a clinical-experimental study of its patho- genesis with special reference to acute infections of the respiratory tract. [Karolinska ...
  9. Emollient Treatments for Atopic Dermatitis: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines - ... 
    https://www.ncbi.nlm.nih.gov/books/NBK544513
    ... of Acceptance from the Eczema Society of Canada. References 1. Weidinger S, Novak N. Atopic dermatitis. Lancet . 2016;387(10023):1109–1122. [ PubMed : 26377142 ] ...
  10. Methotrexate versus Ciclosporin in the Treatment of Severe Atopic Eczema in Children: An economic evaluation - NCBI ... 
    https://www.ncbi.nlm.nih.gov/books/NBK618770
    ... quality-adjusted life-year RCT randomised controlled trial References 1. Williams H. Clinical practice. Atopic dermatitis. N Engl J Med 2005;352:2314–24. ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last